Original article by Natasha Robinson
The Australian – Page: 4 : 28-Oct-21

The Therapeutic Goods Administration has formally approved the use of Pfizer’s COVID-19 vaccine as a booster shot. It will be administered six months after a person has received their first dose of any coronavirus vaccine. Studies have suggested that the efficacy of vaccines declines significantly 3-6 months after they have been administered. However, TGA head John Skerritt has stressed that two doses of an approved vaccine provides strong protection against serious illness, hospitalisation and death. Aged-care residents will be given priority for booster shots, which are expected to become available to the general population from 8 November.

CORPORATES
AUSTRALIA. THERAPEUTIC GOODS ADMINISTRATION